Constructive Bio appoints Dr Feroze Ujjainwalla as Chief Commercial Officer
Constructive Bio appoints Fez Ujjainwalla as CCO to bring its platform for designing and making proteins and peptides with non-canonical…
The Observer Features Constructive Bio’s Sustainable Fermentation Alternative to Peptide Manufacturing Waste
The Observer featured Constructive Bio in coverage of environmental challenges in peptide drug manufacturing, highlighting the company’s fermentation-based approach as…
SynBioBeta Interviews Professor Jason Chin on Constructive Bio’s Expanded Genetic Code and Novel Polymer Applications
SynBioBeta featured an interview with Constructive Bio founder and CSO Professor Jason Chin on expanded genetic codes and novel polymer…
Constructive Bio Partners with RxCelerate to Advance ncAA-Containing Biologics Through Drug Design and Development
Constructive Bio and RxCelerate have partnered to combine programmable biology and ncAA-enabled protein engineering with drug design and development capabilities,…
Constructive Bio Selected as Nature Biotechnology 2025 Editor’s Pick for Synthetic Genomics and ncAA Platform
Constructive Bio was selected by Nature Biotechnology as a 2025 Editor’s Pick, recognising the company’s synthetic genomics platform and use…
Constructive Bio Collaborates with Ellison Institute’s Generative Biology Institute
Constructive Bio entered a collaboration with the Ellison Institute of Technology’s Generative Biology Institute (GBI) in Oxford, combining synthetic genome…
Cambridge iGEM 2025 Team Visits Constructive Bio’s Recodery for Synthetic Biology Discussion
Constructive Bio hosted the Cambridge iGEM 2025 team at The Recodery for a technical discussion on synthetic biology research, as…
Constructive Bio Joins ARIA-Funded Collaboration to Build Synthetic Chloroplast Genomes Using Large-Scale DNA Assembly
Constructive Bio is contributing its large-scale genome assembly platform to an ARIA-funded collaboration with Camena Bioscience and the Max-Planck Institute…
Syn57: MRC LMB Team Led by Constructive Bio’s Jason Chin Creates E. coli with 57-Codon Synthetic Genome
The New York Times covered the creation of Syn57, an E. coli strain with a 57-codon synthetic genome — the…
Professor Jason Chin Reappointed to UK Department for Science, Innovation and Technology Board
Constructive Bio’s founder and CSO, Professor Jason Chin, was reappointed as a Non-Executive Director on the UK Department for Science,…
